_id
6919eed83c536f8df23184fb
Ticker
SVNS.LSE
Name
Solvonis Therapeutics plc
Exchange
LSE
Address
Eccleston Yards, London, United Kingdom, SW1W 9NF
Country
UK
Sector
Industrials
Industry
Specialty Industrial Machinery
Currency
GBX
Website
https://solvonis.com
Description
Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre-clinical stage product candidate includes SVN-SDN-14 for the treatment of post-traumatic stress disorder. The company was formerly known as Graft Polymer (UK) Plc and changed its name to Solvonis Therapeutics plc in January 2025. Solvonis Therapeutics plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
Last Close
2700
Volume
23952004
Current Price
0.2801
Change
11.1111111111111
Last Updated
2025-12-30T11:35:58.011Z
Image
https://logo.clearbit.com/solvonis.com
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2024-12-31
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
349000
Operating Income
-349000
Interest Expense
-
Pretax Income
-349000
Net Income
-335000
Eps
-0.0026948810469048148
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-349000
Operating Margin
-
Total Other Income Expense Net
-
Cash
757000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
815000
Property Plant Equipment
-
Total Assets
3203000
Payables
83000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
119000
Equity
3084000
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
25000
Cash From Operations
-149000
Capital Expenditures
0
Cash From Investing
-20000
Cash From Financing
-
Net Change In Cash
-183000
Cf_currency_symbol
-
PE
-
PB
11.290260082814527
ROE
-10.862516212710766
ROA
-10.458944739306899
FCF
-149000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
349000
Quarters > 0 > income Statement > operating Income
-349000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-349000
Quarters > 0 > income Statement > net Income
-335000
Quarters > 0 > income Statement > eps
-0.0026948810469048148
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
124309754
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-349000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
757000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
815000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
3203000
Quarters > 0 > balance Sheet > payables
83000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
119000
Quarters > 0 > balance Sheet > equity
3084000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-335000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
25000
Quarters > 0 > cash Flow > cash From Operations
-149000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-20000
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-183000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0026948810469048148
Quarters > 0 > ratios > PB
11.290260082814527
Quarters > 0 > ratios > ROE
-10.862516212710766
Quarters > 0 > ratios > ROA
-10.458944739306899
Quarters > 0 > ratios > FCF
-149000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
18000
Quarters > 1 > income Statement > gross Profit
-18000
Quarters > 1 > income Statement > operating Expenses
405000
Quarters > 1 > income Statement > operating Income
-405000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-469000
Quarters > 1 > income Statement > net Income
-626000
Quarters > 1 > income Statement > eps
-0.0050358075682460125
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
124309754
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-348000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-64000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
27000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
44000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
71000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
2139000
Quarters > 1 > balance Sheet > payables
220000
Quarters > 1 > balance Sheet > short Term Debt
264000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
484000
Quarters > 1 > balance Sheet > equity
1655000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-626000
Quarters > 1 > cash Flow > depreciation
57000
Quarters > 1 > cash Flow > change In Working Capital
73000
Quarters > 1 > cash Flow > cash From Operations
-423000
Quarters > 1 > cash Flow > capital Expenditures
4000
Quarters > 1 > cash Flow > cash From Investing
-17000
Quarters > 1 > cash Flow > cash From Financing
312000
Quarters > 1 > cash Flow > net Change In Cash
27000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0050358075682460125
Quarters > 1 > ratios > PB
21.038768637703928
Quarters > 1 > ratios > ROE
-37.82477341389728
Quarters > 1 > ratios > ROA
-29.266012155212717
Quarters > 1 > ratios > FCF
-427000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
347000
Quarters > 2 > income Statement > cost Of Revenue
317000
Quarters > 2 > income Statement > gross Profit
30000
Quarters > 2 > income Statement > operating Expenses
2118000
Quarters > 2 > income Statement > operating Income
-2088000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1994000
Quarters > 2 > income Statement > net Income
-1994000
Quarters > 2 > income Statement > eps
-0.019169875369564483
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
104017369
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1919000
Quarters > 2 > income Statement > operating Margin
-601.7291066282421
Quarters > 2 > income Statement > total Other Income Expense Net
94000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
155000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
71000
Quarters > 2 > balance Sheet > inventories
51000
Quarters > 2 > balance Sheet > total Current Assets
314000
Quarters > 2 > balance Sheet > property Plant Equipment
39000
Quarters > 2 > balance Sheet > total Assets
2434000
Quarters > 2 > balance Sheet > payables
159000
Quarters > 2 > balance Sheet > short Term Debt
12000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
408000
Quarters > 2 > balance Sheet > equity
2026000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-1994000
Quarters > 2 > cash Flow > depreciation
83000
Quarters > 2 > cash Flow > change In Working Capital
-228000
Quarters > 2 > cash Flow > cash From Operations
-345000
Quarters > 2 > cash Flow > capital Expenditures
21000
Quarters > 2 > cash Flow > cash From Investing
5000
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-367000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.019169875369564483
Quarters > 2 > ratios > PB
14.3806836411155
Quarters > 2 > ratios > ROE
-98.42053307008885
Quarters > 2 > ratios > ROA
-81.9227608874281
Quarters > 2 > ratios > FCF
-366000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0547550432276658
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
240000
Quarters > 3 > income Statement > cost Of Revenue
303000
Quarters > 3 > income Statement > gross Profit
-63000
Quarters > 3 > income Statement > operating Expenses
966000
Quarters > 3 > income Statement > operating Income
-1029000
Quarters > 3 > income Statement > interest Expense
3000
Quarters > 3 > income Statement > pretax Income
-1126000
Quarters > 3 > income Statement > net Income
-1126000
Quarters > 3 > income Statement > eps
-0.010816810503188322
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
104097229
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1029000
Quarters > 3 > income Statement > operating Margin
-428.74999999999994
Quarters > 3 > income Statement > total Other Income Expense Net
-97001
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
522000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
104000
Quarters > 3 > balance Sheet > inventories
114000
Quarters > 3 > balance Sheet > total Current Assets
772000
Quarters > 3 > balance Sheet > property Plant Equipment
852000
Quarters > 3 > balance Sheet > total Assets
3705000
Quarters > 3 > balance Sheet > payables
111000
Quarters > 3 > balance Sheet > short Term Debt
13000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
239000
Quarters > 3 > balance Sheet > equity
3466000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1126000
Quarters > 3 > cash Flow > depreciation
94000
Quarters > 3 > cash Flow > change In Working Capital
97000
Quarters > 3 > cash Flow > cash From Operations
-893000
Quarters > 3 > cash Flow > capital Expenditures
237000
Quarters > 3 > cash Flow > cash From Investing
-237000
Quarters > 3 > cash Flow > cash From Financing
1640000
Quarters > 3 > cash Flow > net Change In Cash
-1118000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.010816810503188322
Quarters > 3 > ratios > PB
8.412473699624929
Quarters > 3 > ratios > ROE
-32.4870167339873
Quarters > 3 > ratios > ROA
-30.39136302294197
Quarters > 3 > ratios > FCF
-1130000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4.708333333333333
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1383000
Annuals > 0 > income Statement > operating Income
-1383000
Annuals > 0 > income Statement > interest Expense
64000
Annuals > 0 > income Statement > pretax Income
-1447000
Annuals > 0 > income Statement > net Income
-1590000
Annuals > 0 > income Statement > eps
-0.0013745620215308456
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1156732090
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1383000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-64000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
757000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
815000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
3203000
Annuals > 0 > balance Sheet > payables
83000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
119000
Annuals > 0 > balance Sheet > equity
3084000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-1590000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-27000
Annuals > 0 > cash Flow > cash From Operations
-1130000
Annuals > 0 > cash Flow > capital Expenditures
4000
Annuals > 0 > cash Flow > cash From Investing
-337000
Annuals > 0 > cash Flow > cash From Financing
2083000
Annuals > 0 > cash Flow > net Change In Cash
602000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.0013745620215308456
Annuals > 0 > ratios > PB
111.77242633592736
Annuals > 0 > ratios > ROE
-51.55642023346303
Annuals > 0 > ratios > ROA
-49.640961598501406
Annuals > 0 > ratios > FCF
-1134000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
587000
Annuals > 1 > income Statement > cost Of Revenue
446000
Annuals > 1 > income Statement > gross Profit
-134000
Annuals > 1 > income Statement > operating Expenses
3258000
Annuals > 1 > income Statement > operating Income
-3117000
Annuals > 1 > income Statement > interest Expense
3000
Annuals > 1 > income Statement > pretax Income
-3120000
Annuals > 1 > income Statement > net Income
-3120000
Annuals > 1 > income Statement > eps
-0.02998348054373389
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
104057299
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-2938000
Annuals > 1 > income Statement > operating Margin
-531.0051107325382
Annuals > 1 > income Statement > total Other Income Expense Net
-3000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
155000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
71000
Annuals > 1 > balance Sheet > inventories
51000
Annuals > 1 > balance Sheet > total Current Assets
314000
Annuals > 1 > balance Sheet > property Plant Equipment
39000
Annuals > 1 > balance Sheet > total Assets
2434000
Annuals > 1 > balance Sheet > payables
159000
Annuals > 1 > balance Sheet > short Term Debt
12000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
408000
Annuals > 1 > balance Sheet > equity
2026000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-3120000
Annuals > 1 > cash Flow > depreciation
177000
Annuals > 1 > cash Flow > change In Working Capital
413000
Annuals > 1 > cash Flow > cash From Operations
-1238000
Annuals > 1 > cash Flow > capital Expenditures
232000
Annuals > 1 > cash Flow > cash From Investing
-232000
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-1485000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-0.02998348054373389
Annuals > 1 > ratios > PB
15.305565203356368
Annuals > 1 > ratios > ROE
-153.9980256663376
Annuals > 1 > ratios > ROA
-128.18405916187345
Annuals > 1 > ratios > FCF
-1470000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.504258943781942
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
542000
Annuals > 2 > income Statement > cost Of Revenue
593000
Annuals > 2 > income Statement > gross Profit
-50999
Annuals > 2 > income Statement > operating Expenses
2657000
Annuals > 2 > income Statement > operating Income
-2708000
Annuals > 2 > income Statement > interest Expense
4000
Annuals > 2 > income Statement > pretax Income
-2705000
Annuals > 2 > income Statement > net Income
-2705000
Annuals > 2 > income Statement > eps
-0.026112690459617043
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
103589479
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-2588000
Annuals > 2 > income Statement > operating Margin
-499.6309963099631
Annuals > 2 > income Statement > total Other Income Expense Net
-4000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
1640000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
43000
Annuals > 2 > balance Sheet > inventories
187000
Annuals > 2 > balance Sheet > total Current Assets
2157000
Annuals > 2 > balance Sheet > property Plant Equipment
701000
Annuals > 2 > balance Sheet > total Assets
4939000
Annuals > 2 > balance Sheet > payables
185000
Annuals > 2 > balance Sheet > short Term Debt
4000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
385000
Annuals > 2 > balance Sheet > equity
4554000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-2705000
Annuals > 2 > cash Flow > depreciation
113000
Annuals > 2 > cash Flow > change In Working Capital
-640000
Annuals > 2 > cash Flow > cash From Operations
-2360000
Annuals > 2 > cash Flow > capital Expenditures
718000
Annuals > 2 > cash Flow > cash From Investing
-718000
Annuals > 2 > cash Flow > cash From Financing
4135000
Annuals > 2 > cash Flow > net Change In Cash
1042000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-0.026112690459617043
Annuals > 2 > ratios > PB
6.778582508124725
Annuals > 2 > ratios > ROE
-59.39833113746157
Annuals > 2 > ratios > ROA
-54.76817169467504
Annuals > 2 > ratios > FCF
-3078000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-5.678966789667896
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
219000
Annuals > 3 > income Statement > cost Of Revenue
164000
Annuals > 3 > income Statement > gross Profit
55000
Annuals > 3 > income Statement > operating Expenses
900000
Annuals > 3 > income Statement > operating Income
-845000
Annuals > 3 > income Statement > interest Expense
8000
Annuals > 3 > income Statement > pretax Income
-954000
Annuals > 3 > income Statement > net Income
-954000
Annuals > 3 > income Statement > eps
-0.009164502913759559
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
104097299
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-900000
Annuals > 3 > income Statement > operating Margin
-385.84474885844753
Annuals > 3 > income Statement > total Other Income Expense Net
-109000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
598000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
43000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
740000
Annuals > 3 > balance Sheet > property Plant Equipment
310000
Annuals > 3 > balance Sheet > total Assets
3130000
Annuals > 3 > balance Sheet > payables
841000
Annuals > 3 > balance Sheet > short Term Debt
950000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2318000
Annuals > 3 > balance Sheet > equity
812000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-954000
Annuals > 3 > cash Flow > depreciation
46000
Annuals > 3 > cash Flow > change In Working Capital
646000
Annuals > 3 > cash Flow > cash From Operations
-254000
Annuals > 3 > cash Flow > capital Expenditures
1000
Annuals > 3 > cash Flow > cash From Investing
-1000
Annuals > 3 > cash Flow > cash From Financing
800000
Annuals > 3 > cash Flow > net Change In Cash
389000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.009164502913759559
Annuals > 3 > ratios > PB
38.20319593842365
Annuals > 3 > ratios > ROE
-117.48768472906403
Annuals > 3 > ratios > ROA
-30.47923322683706
Annuals > 3 > ratios > FCF
-255000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.1643835616438356
Annuals > 3 > health Score
12
Valuation > metrics > PE
-0.0026948810469048148
Valuation > metrics > PB
11.290260082814527
Valuation > final Score
20
Valuation > verdict
276.3% Overvalued
Profitability > metrics > ROE
-10.862516212710766
Profitability > metrics > ROA
-41.104294478527606
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.03858625162127108
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
9.819277108433734
Liquidity > metrics > Quick Ratio
9.819277108433734
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
47
Prev Risks > 1
-51
Prev Risks > 2
-1312
Prev Liquidities > 0
17
Prev Liquidities > 1
96
Prev Liquidities > 2
100
Updated At
2026-01-20T23:04:19.516Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0006
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.0006
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-07
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2024-12-31
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0146
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-09-30
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0812
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-03-31
Earnings History > 4 > report Date
2023-04-27
Earnings History > 4 > date
2023-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-09-30
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-
Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre-clinical stage product candidate includes SVN-SDN-14 for the treatment of post-traumatic stress disorder. The company was formerly known as Graft Polymer (UK) Plc and changed its name to Solvonis Therapeutics plc in January 2025. Solvonis Therapeutics plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFTSE 100 Live: London stocks spooked lower as October winds up Proactive Investors
Read more →Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth Investing News Network
Read more →Showing 2 of 8
(Last Updated 2024-12-31)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Solvonis Therapeutics plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.0006
EPS Estimate
0
EPS Difference
-0.0006
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
ÂŁ 0
Cost Of Revenue
ÂŁ 0
Gross Profit
ÂŁ 0
Operating Expenses
ÂŁ 0
Operating Income
ÂŁ 0
Interest Expense
ÂŁ 0
Pretax Income
ÂŁ 0
Net Income
ÂŁ 0
Income Tax Expense
ÂŁ 0
EBITDA
ÂŁ 0
Total Other Income Expense Net
ÂŁ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
ÂŁ 0
Short Term Investments
ÂŁ 0
Receivables
ÂŁ 0
Inventories
ÂŁ 0
Total Current Assets
ÂŁ 0
Property Plant Equipment
ÂŁ 0
Total Assets
ÂŁ 0
Payables
ÂŁ 0
Short Term Debt
ÂŁ 0
Long Term Debt
ÂŁ 0
Total Liabilities
ÂŁ 0
Equity
ÂŁ 0
(Last Updated 2024-12-31)
Net Income
ÂŁ 0
Depreciation
ÂŁ 0
Change In Working Capital
ÂŁ 0
Cash From Operations
ÂŁ 0
Capital Expenditures
ÂŁ 0
Cash From Investing
ÂŁ 0
Cash From Financing
ÂŁ 0
Net Change In Cash
ÂŁ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.